Healthcare -
Biotechnology - NASDAQ - US
$ 8.09
-1.17 %
$ 838 M
Market Cap
-1.45
P/E
NTLA - CASH FROM OPERATIONS
Cash from Operations NTLA - Intellia Therapeutics, Inc.
-349 M
LAST VALUE
-2.31%
2 YEAR CAGR
-27.58%
5 YEAR CAGR
-58.52%
10 YEAR CAGR